Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours
- 1 October 1996
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 74 (7) , 1069-1073
- https://doi.org/10.1038/bjc.1996.491
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Loh and mutation analysis of CDKN2 in primary human ovarian cancersInternational Journal of Cancer, 1995
- Homozygous Deletions and Loss of Expression of the CDKN2 gene occur frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumorsGenes, Chromosomes and Cancer, 1995
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- Somatic Mutations of the MTS (Multiple Tumor Suppressor) 1/CDK41 (Cyclin-Dependent Kinase-4 Inhibitor) Gene in Human Primary Non-small Cell Lung CarcinomasBiochemical and Biophysical Research Communications, 1994
- P16 gene in uncultured tumoursNature, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancersNature, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993